Intranuclear iron deposition in hepatocytes and renal tubular cells in mice treated with ferric nitrilotriacetate

被引:0
|
作者
Asami Kondo
Jiro Deguchi
Shigeru Okada
机构
[1] Department of Pathology,
[2] Okayama University Medical School,undefined
[3] 2-5-1 Shikata-cho,undefined
[4] Okayama 700-8558,undefined
[5] Japan Fax: +81-86-235-7148,undefined
[6] Sumitomo Pharmaceuticals Research Centre 1-98,undefined
[7] Kasugadenaka 3-chome,undefined
[8] Konohanaku,undefined
[9] Osaka 544-0022,undefined
[10] Japan,undefined
来源
Virchows Archiv | 1998年 / 433卷
关键词
Key words Intranuclear iron deposition; Ferric nitrilotriacetate; Ferritin; Renal tumours;
D O I
暂无
中图分类号
学科分类号
摘要
 Cytoplasmic and intranuclear iron depositions were observed in the livers and kidneys of male and female ddY mice treated for 4–12 weeks with ferric nitrilotriacetate (Fe-NTA), a known renal carcinogen that acts through the production of free radicals. The intranuclear iron deposition consisted of a spherical aggregation of ferritin particles of approximately 10 nm diameter, as revealed by immunohistochemical staining and electron microscopy. Although the incidence of renal tumours was greater in the males than in the females, the incidence of iron depositions did not differ with gender. The most abundant intranuclear iron depositions were observed in the animals treated with Fe-NTA for the longest duration (12 weeks). These findings suggest that the intranuclear production and propagation of free radical reactions are prevented by the trapping of iron in a chemically inert iron form of ferritin.
引用
收藏
页码:543 / 548
页数:5
相关论文
共 50 条
  • [1] Intranuclear iron deposition in hepatocytes and renal tubular cells in mice treated with ferric nitrilotriacetate
    Kondo, A
    Deguchi, J
    Okada, S
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1998, 433 (06): : 543 - 548
  • [2] SUBACUTE NEPHROTOXICITY AND INDUCTION OF RENAL-CELL CARCINOMA IN MICE TREATED WITH FERRIC NITRILOTRIACETATE
    LI, JL
    OKADA, S
    HAMAZAKI, S
    EBINA, Y
    MIDORIKAWA, O
    CANCER RESEARCH, 1987, 47 (07) : 1867 - 1869
  • [3] Ferric nitrilotriacetate induced renal tumorigenesis in MUTYH deficient mice
    Akatsuka, Shinya
    Li, Guang-Hua
    Sakumi, Kunihiko
    Nakabeppu, Yusaku
    Futakuchi, Mitsuru
    Suzuki, Hiromu
    Toyokuni, Shinya
    CANCER SCIENCE, 2018, 109 : 167 - 167
  • [4] Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate
    Okazaki, Y
    Iqbal, M
    Okada, S
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1740 (03): : 357 - 366
  • [5] In vitro transformation of rat renal cells by treatment with ferric nitrilotriacetate
    Kakehashi, C
    Mori, M
    Kawabata, T
    Okada, S
    ACTA MEDICA OKAYAMA, 2001, 55 (02) : 97 - 103
  • [6] RENAL CYSTS AND ASSOCIATED RENAL TUMORS IN MALE DDY MICE INJECTED WITH FERRIC NITRILOTRIACETATE
    KONDO, A
    DEGUCHI, J
    OKADA, S
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1995, 427 (01): : 91 - 99
  • [8] DNA-BASE MODIFICATIONS IN RENAL CHROMATIN OF WISTAR RATS TREATED WITH A RENAL CARCINOGEN, FERRIC NITRILOTRIACETATE
    TOYOKUNI, S
    MORI, T
    DIZDAROGLU, M
    INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (01) : 123 - 128
  • [9] Genomic distribution of 8-oxoguanines in the kidney genome of ferric nitrilotriacetate -treated mice
    Akatsuka, Shinya
    Toyokuni, Shinya
    CANCER SCIENCE, 2024, 115 : 1279 - 1279
  • [10] Induction of hepatic and renal metallothionein synthesis by ferric nitrilotriacetate in mice: the role of MT as an antioxidant
    Min, KS
    Morishita, F
    Tetsuchikawahara, N
    Onosaka, S
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 204 (01) : 9 - 17